Related Experiment Video
Updated: Apr 3, 2026
08:50
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
12.4K
Percutaneous aortic valve interventions in heart failure patients
M Urena1, D Himbert, J Rodés-Cabau
1Bichat Claude Bernard Hospital, Paris VII University, Paris, France - dominique.himbert@aphp.fr.
Minerva Cardioangiologica
|September 24, 2015
Summary
Heart failure in aortic stenosis significantly reduces survival. Minimally invasive transcatheter aortic valve implantation (TAVI) and percutaneous balloon aortic valvuloplasty (PBAV) offer improved outcomes for high-risk patients.
Area of Science:
- Cardiology
- Cardiac Surgery
- Interventional Cardiology
Background:
- Heart failure onset in aortic stenosis drastically reduces survival.
- Aortic valve replacement improves life expectancy, but heart failure and left ventricular dysfunction predict poor surgical outcomes.
- These conditions often lead to denial of surgical aortic valve replacement in elderly patients.
Purpose of the Study:
- To discuss the evidence for transcatheter aortic valve implantation (TAVI) and percutaneous balloon aortic valvuloplasty (PBAV) in patients with aortic stenosis and heart failure.
- To propose a management strategy for this high-risk patient group.
Main Methods:
- Review of available evidence on PBAV and TAVI outcomes in patients with heart failure and/or left ventricular systolic dysfunction.
- Discussion of current therapeutic options and management strategies.
Main Results:
- Transcatheter aortic valve implantation (TAVI) and percutaneous balloon aortic valvuloplasty (PBAV) are established therapies for high-risk patients.
- These minimally invasive procedures are suitable for patients with heart failure and/or left ventricular systolic dysfunction.
Conclusions:
- TAVI and PBAV represent appealing therapeutic options for high-risk aortic stenosis patients with heart failure.
- Evidence supports the use of these minimally invasive techniques, with a proposed management strategy to guide clinical practice.
More Related Videos
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
552
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
552
01:22Heart Failure VI: Adjunct Therapies
580
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
580
01:17Aortic Regurgitation IV: Nursing Management
410
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
410
01:26Mitral Stenosis III: Medical Management
466
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
466
01:27Peripheral Artery Disease III: Interprofessional Care
583
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
583
01:29Cardiomyopathy V: Interprofessional Care
647
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
647